Position
Essential Partners LLC in Neumora Therapeutics, Inc.
Back to the book · All holders of NMRA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1$1.82 → $1.80
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q2 2025 | 1.14K | $836 | — | — | — | 0.0% |
| Q3 2025 | 690 | $1.26K | $1.82 | $750 | −$330 | 0.0% |
| Q4 2025 | 30 | $54 | $1.80 | −$1 | −$1.2K | 0.0% |